Three New Medicaid Bulletin Articles Available

The NC Division of Health Benefits (DHB) has recently published three new Medicaid Bulletin articles. Below are exerts or summaries of some of the most recent articles and links for more details. All articles may be found on the DHB website.

 

Cefiderocol for Injection, for Intravenous Use (Fetroja®) HCPCS Code J3490: Billing Guidelines

Effective with date of service Feb. 24, 2020, the Medicaid and NC Health Choice programs cover cefiderocol for injection, for intravenous use (Fetroja®) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J3490 - Unclassified drugs. More information

 

Cetirizine Hydrochloride Injection, for Intravenous Use (Quzyttir™) HCPCS Code J3490: Billing Guidelines

Effective with date of service Feb. 19, 2020, the Medicaid and NC Health Choice programs cover cetirizine hydrochloride injection, for intravenous use (Quzyttir™) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J3490 - Unclassified drugs. Details 

 

Trastuzumab-Qyyp for Injection, for Intravenous Use (Trazimera™) HCPCS Code Q5116: Billing Guidelines

Effective with date of service Feb. 15, 2020, the Medicaid and NC Health Choice programs cover trastuzumab-qyyp for injection, for intravenous use (Trazimera™) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code Q5116 - Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg. Read more